ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.

Autor: Avoranta ST; Department of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Hämeentie 11, FIN-20521, Turku, Finland. stavor@utu.fi, Korkeila EA, Ristamäki RH, Syrjänen KJ, Carpén OM, Pyrhönen SO, Sundström JT

Publikováno v: Human pathology [Hum Pathol] 2013 Jun; Vol. 44 (6), pp. 966-74. Date of Electronic Publication: 2013 Jan 17.

Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy.

Autor: Avoranta ST; Department of Oncology and Radiotherapy, University of Turku, Turku University Hospital, Finland. stavor@utu.fi, Korkeila EA, Minn HR, Syrjänen KJ, Pyrhönen SO, Sundström JT

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2011 Nov; Vol. 50 (8), pp. 1158-66.